Diagnostics antibodies and antigens for Inflammation/autoimmune/inflammatory diseases
Inflammation/autoimmune/inflammatory diseases occur when the immune system attacks the normal tissue within joints, vasculature, and other organ systems, causing inflammation, pain, diminished mobility, fatigue, and other non-specific symptoms. The strong overlap of signs and symptoms among the autoimmune diseases can lead to delays in diagnosis and appropriate treatment. However, immunodiagnostics has been developed to detect the inflammation/autoimmune/inflammatory disease such as ankylosing spondylitis, bacterial infections, bacterial meningitis, cerebrovascular diseases, crohn's disease, fungal infection, graves' disease, inflammatory amyloidosis, inflammatory bowel disease, mog antibody disease, osteomyelitis, rheumatoid arthritis, sepsis, respiratory illnesses and so on at an early stage. Biomarkers have been developed to detect this autoimmune disease at an early stage. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Classification:
IL-6
PCT
CRP
SAA
IFNγ
AQP4
HBP
MOG
S100-A9
TPO
SAA1
TNFα
MPA
CCP
alpha defensin 1
alpha defensin 5
Tolfenamicacid
Carprofen
Flunixin meglumine
Metamizole
DZP
Indomethacin
melloxacan
LF
FITC
Histamine
COC
COT
Interleukin 6 (IL-6)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-IL-6 | Human | Interleukin 6 (IL-6) | systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease. | GMP-h-IL-6-Ag01: Recombinant human IL-6 Protein |
Interleukin 6 (IL-6) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in IL-6 level test of Inflammation/autoimmune/inflammatory disease(systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. | GMP-h-IL-6-Ab01; GMP-h-IL-6-Ab02: Anti-human IL-6 mouse monoclonal antibody(mAb) |
Human Interleukin 6 (IL-6) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Interleukin 6 (IL-6) antibodies in IL-6 level test of Inflammation/autoimmune/inflammatory disease (systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) and related syndrome evaluation. |
procalcitonin (PCT)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-PCT | Human | procalcitonin (PCT) | Sepsis; Respiratory illnesses; bacterial meningitis and etc. | GMP-h-PCT-Ag01: Recombinant human PCT Protein |
procalcitonin (PCT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PCT level test of Inflammation/autoimmune/inflammatory disease(Sepsis; Respiratory illnesses; bacterial meningitis and etc.) and related syndrome evaluation. | GMP-h-PCT-Ab01; GMP-h-PCT-Ab02: Anti-human PCT mouse monoclonal antibody(mAb) |
Human procalcitonin (PCT) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other procalcitonin (PCT) antibodies in PCT level test of Inflammation/autoimmune/inflammatory disease (Sepsis; Respiratory illnesses; bacterial meningitis and etc.) and related syndrome evaluation. |
C-Reactive Protein (CRP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-CRP | Human | C-Reactive Protein (CRP) | Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis | GMP-h-CRP-Ag01: Recombinant human CRP Protein |
C-Reactive Protein (CRP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in CRP level test of Inflammation/autoimmune/inflammatory disease(Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis) and related syndrome evaluation. | GMP-h-CRP-Ab01; GMP-h-CRP-Ab02: Anti-human CRP mouse monoclonal antibody(mAb) |
Human C-Reactive Protein (CRP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-Reactive Protein (CRP) antibodies in CRP level test of Inflammation/autoimmune/inflammatory disease (Bacterial infections, sepsis, fungal infection, Inflammatory bowel disease, autoimmune, cancer and etc disorder, osteomyelitis) and related syndrome evaluation. |
Serum Amyloid A (SAA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SAA | Human | Serum Amyloid A (SAA) | Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections | GMP-h-SAA-Ag01: Recombinant human SAA Protein |
Serum Amyloid A (SAA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAA level test of Inflammation/autoimmune/inflammatory disease(Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections) and related syndrome evaluation. | GMP-h-SAA-Ab01; GMP-h-SAA-Ab02: Anti-human SAA mouse monoclonal antibody(mAb) |
Human Serum Amyloid A (SAA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A (SAA) antibodies in SAA level test of Inflammation/autoimmune/inflammatory disease (Rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), and chronic infections) and related syndrome evaluation. |
Interferon gamma (IFNγ)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-IFNγ | Human | Interferon gamma (IFNγ) | inflamation, autoimmune disease | GMP-h-IFNγ-Ag01: Recombinant human IFNγ Protein |
Interferon gamma (IFNγ) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in IFNγ level test of Inflammation/autoimmune/inflammatory disease(inflamation, autoimmune disease) and related syndrome evaluation. | GMP-h-IFNγ-Ab01; GMP-h-IFNγ-Ab02: Anti-human IFNγ mouse monoclonal antibody(mAb) |
Human Interferon gamma (IFNγ) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Interferon gamma (IFNγ) antibodies in IFNγ level test of Inflammation/autoimmune/inflammatory disease (inflamation, autoimmune disease) and related syndrome evaluation. |
aquaporin-4 (AQP4)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-AQP4 | Human | aquaporin-4 (AQP4) | Cerebrovascular diseases | GMP-h-AQP4-Ag01: Recombinant human AQP4 Protein |
aquaporin-4 (AQP4) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in AQP4 level test of Inflammation/autoimmune/inflammatory disease(Cerebrovascular diseases) and related syndrome evaluation. | GMP-h-AQP4-Ab01; GMP-h-AQP4-Ab02: Anti-human AQP4 mouse monoclonal antibody(mAb) |
Human aquaporin-4 (AQP4) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other aquaporin-4 (AQP4) antibodies in AQP4 level test of Inflammation/autoimmune/inflammatory disease (Cerebrovascular diseases) and related syndrome evaluation. |
Heparin-binding protein (HBP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-HBP | Human | Heparin-binding protein (HBP) | inflammation/autoimmune/ inflammatory disease | GMP-h-HBP-Ag01: Recombinant human HBP Protein |
Heparin-binding protein (HBP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in HBP level test of Inflammation/autoimmune/inflammatory disease(inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. | GMP-h-HBP-Ab01; GMP-h-HBP-Ab02: Anti-human HBP mouse monoclonal antibody(mAb) |
Human Heparin-binding protein (HBP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heparin-binding protein (HBP) antibodies in HBP level test of Inflammation/autoimmune/inflammatory disease (inflammation/autoimmune/ inflammatory disease) and related syndrome evaluation. |
myelin oligodendrocyte glycoprotein (MOG)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-MOG | Human | myelin oligodendrocyte glycoprotein (MOG) | MOG antibody disease | GMP-h-MOG-Ag01: Recombinant human MOG Protein |
myelin oligodendrocyte glycoprotein (MOG) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in MOG level test of Inflammation/autoimmune/inflammatory disease(MOG antibody disease) and related syndrome evaluation. | GMP-h-MOG-Ab01; GMP-h-MOG-Ab02: Anti-human MOG mouse monoclonal antibody(mAb) |
Human myelin oligodendrocyte glycoprotein (MOG) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other myelin oligodendrocyte glycoprotein (MOG) antibodies in MOG level test of Inflammation/autoimmune/inflammatory disease (MOG antibody disease) and related syndrome evaluation. |
Calprotectin heavy chain (S100-A9)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-S100-A9 | Human | Calprotectin heavy chain (S100-A9) | inflammatory bowel disease | GMP-h-S100-A9-Ag01: Recombinant human S100-A9 Protein |
Calprotectin heavy chain (S100-A9) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in S100-A9 level test of Inflammation/autoimmune/inflammatory disease(inflammatory bowel disease) and related syndrome evaluation. | GMP-h-S100-A9-Ab01; GMP-h-S100-A9-Ab02: Anti-human S100-A9 mouse monoclonal antibody(mAb) |
Human Calprotectin heavy chain (S100-A9) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Calprotectin heavy chain (S100-A9) antibodies in S100-A9 level test of Inflammation/autoimmune/inflammatory disease (inflammatory bowel disease) and related syndrome evaluation. |
Thyroid peroxidase (TPO)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TPO | Human | Thyroid peroxidase (TPO) | Hashimoto's disease or Graves' disease | GMP-h-TPO-Ag01: Recombinant human TPO Protein |
Thyroid peroxidase (TPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TPO level test of Inflammation/autoimmune/inflammatory disease(Hashimoto's disease or Graves' disease) and related syndrome evaluation. | GMP-h-TPO-Ab01; GMP-h-TPO-Ab02: Anti-human TPO mouse monoclonal antibody(mAb) |
Human Thyroid peroxidase (TPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Thyroid peroxidase (TPO) antibodies in TPO level test of Inflammation/autoimmune/inflammatory disease (Hashimoto's disease or Graves' disease) and related syndrome evaluation. |
Serum Amyloid A1 (SAA1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-SAA1 | Human | Serum Amyloid A1 (SAA1) | Inflammatory amyloidosis | GMP-h-SAA1-Ag01: Recombinant human SAA1 Protein |
Serum Amyloid A1 (SAA1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in SAA1 level test of Inflammation/autoimmune/inflammatory disease(Inflammatory amyloidosis) and related syndrome evaluation. | GMP-h-SAA1-Ab01; GMP-h-SAA1-Ab02: Anti-human SAA1 mouse monoclonal antibody(mAb) |
Human Serum Amyloid A1 (SAA1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Serum Amyloid A1 (SAA1) antibodies in SAA1 level test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome evaluation. |
tumor necrosis factor alpha (TNFα)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-TNFα | Human | tumor necrosis factor alpha (TNFα) | rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease | GMP-h-TNFα-Ag01: Recombinant human TNFα Protein |
tumor necrosis factor alpha (TNFα) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in TNFα level test of Inflammation/autoimmune/inflammatory disease(rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease) and related syndrome evaluation. | GMP-h-TNFα-Ab01; GMP-h-TNFα-Ab02: Anti-human TNFα mouse monoclonal antibody(mAb) |
Human tumor necrosis factor alpha (TNFα) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other tumor necrosis factor alpha (TNFα) antibodies in TNFα level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease) and related syndrome evaluation. |
mycophenolic acid (MPA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-MPA | Human | mycophenolic acid (MPA) | autoimmune disease | GMP-SMT-MPA-Ag01: BSA-mycophenolic acid (MPA); GMP-SMT-MPA-Ag02: OVA-mycophenolic acid (MPA) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-mycophenolic acid (MPA)], mycophenolic acid (MPA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. | GMP-SMT-MPA-Ab01: Anti-mycophenolic acid (MPA) mouse monoclonal antibody(mAb) |
Human mycophenolic acid (MPA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. |
cyclic citrullinated peptide (CCP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-CCP | Human | cyclic citrullinated peptide (CCP) | rheumatoid arthritis | GMP-SMT-CCP-Ag01: BSA-cyclic citrullinated peptide (CCP); GMP-SMT-CCP-Ag02: OVA-cyclic citrullinated peptide (CCP) |
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-cyclic citrullinated peptide (CCP)], cyclic citrullinated peptide (CCP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in CCP level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis) and related syndrome evaluation. | GMP-SMT-CCP-Ab01: Anti-cyclic citrullinated peptide (CCP) mouse monoclonal antibody(mAb) |
Human cyclic citrullinated peptide (CCP) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in CCP level test of Inflammation/autoimmune/inflammatory disease (rheumatoid arthritis) and related syndrome evaluation. |
alpha defensin 1 (α-defensin 1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-a-defensin-1 | Human | alpha defensin 1 (α-defensin 1) | Prosthetic joint infection (PJI) | GMP-h-a-defensin-1-Ag01: Peptide Human alpha defensin 1 (α-defensin 1) protein |
alpha defensin 1 (α-defensin 1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation | GMP-h-a-defensin-1-Ab01: GMP-h-a-defensin-1-Ab02: Anti-Human α-defensin 1 mouse monoclonal antibody (mAb) |
Human alpha defensin 1 (α-defensin 1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 1 (α-defensin 1) antibodies in α-defensin 1 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. |
alpha defensin 5 (α-defensin 5)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-h-a-defensin-5 | Human | alpha defensin 5 (α-defensin 5) | Prosthetic joint infection (PJI) | GMP-h-a-defensin-5-Ag01: Peptide Human alpha defensin 5 (α-defensin 5) protein |
alpha defensin 5 (α-defensin 5) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in α-defensin 5 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation | GMP-h-a-defensin-5-Ab01: GMP-h-a-defensin-5-Ab02: Anti-Human α-defensin 5 mouse monoclonal antibody (mAb) |
Human alpha defensin 5 (α-defensin 5) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other alpha defensin 5 (α-defensin 5) antibodies in α-defensin 5 level test of Inflammation/autoimmune/inflammatory disease (Prosthetic joint infection (PJI)) and related syndrome evaluation. |
Tolfenamicacid
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-197 | Human | Tolfenamicacid | GMP-SMT-197-Ag01: BSA-Tolfenamicacid GMP-SMT-197-Ag02: OVA-Tolfenamicacid | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Tolfenamicacid, Tolfenamicacid antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Tolfenamicacid level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-197-Ab01: Anti-Tolfenamicacid mouse monoclonal antibody(mAb) GMP-SMT-197-Ab02: Anti-Tolfenamicacid human monoclonal antibody(mAb) | Tolfenamicacid antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Tolfenamicacid antibodies in Tolfenamicacid level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Carprofen
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-198 | Human | Carprofen | GMP-SMT-198-Ag01: BSA-Carprofen GMP-SMT-198-Ag02: OVA-Carprofen | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Carprofen, Carprofen antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Carprofen level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-198-Ab01: Anti-Carprofen mouse monoclonal antibody(mAb) GMP-SMT-198-Ab02: Anti-Carprofen human monoclonal antibody(mAb) | Carprofen antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Carprofen antibodies in Carprofen level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Flunixin meglumine
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-199 | Human | Flunixin meglumine | GMP-SMT-199-Ag01: BSA-Flunixin meglumine GMP-SMT-199-Ag02: OVA-Flunixin meglumine | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Flunixin meglumine, Flunixin meglumine antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Flunixin meglumine level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-199-Ab01: Anti-Flunixin meglumine mouse monoclonal antibody(mAb) GMP-SMT-199-Ab02: Anti-Flunixin meglumine human monoclonal antibody(mAb) | Flunixin meglumine antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Flunixin meglumine antibodies in Flunixin meglumine level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Metamizole
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-201 | Human | Metamizole | GMP-SMT-201-Ag01: BSA-Metamizole GMP-SMT-201-Ag02: OVA-Metamizole | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Metamizole, Metamizole antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Metamizole level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-201-Ab01: Anti-Metamizole mouse monoclonal antibody(mAb) GMP-SMT-201-Ab02: Anti-Metamizole human monoclonal antibody(mAb) | Metamizole antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Metamizole antibodies in Metamizole level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Diazepam(DZP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-203 | Human | Diazepam(DZP) | anxiety, seizures, muscle spasms | GMP-SMT-203-Ag01: BSA-Diazepam(DZP) GMP-SMT-203-Ag02: OVA-Diazepam(DZP) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Diazepam(DZP), Diazepam(DZP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation. | GMP-SMT-203-Ab01: Anti-Diazepam(DZP) mouse monoclonal antibody(mAb) GMP-SMT-203-Ab02: Anti-Diazepam(DZP) human monoclonal antibody(mAb) | Diazepam(DZP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Diazepam(DZP) antibodies in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation. |
Indomethacin
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-205 | Human | Indomethacin | GMP-SMT-205-Ag01: BSA-Indomethacin GMP-SMT-205-Ag02: OVA-Indomethacin | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Indomethacin, Indomethacin antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Indomethacin level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-205-Ab01: Anti-Indomethacin mouse monoclonal antibody(mAb) GMP-SMT-205-Ab02: Anti-Indomethacin human monoclonal antibody(mAb) | Indomethacin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Indomethacin antibodies in Indomethacin level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
melloxacan
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-206 | Human | melloxacan | GMP-SMT-206-Ag01: BSA-melloxacan GMP-SMT-206-Ag02: OVA-melloxacan | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-melloxacan, melloxacan antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in melloxacan level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-206-Ab01: Anti-melloxacan mouse monoclonal antibody(mAb) GMP-SMT-206-Ab02: Anti-melloxacan human monoclonal antibody(mAb) | melloxacan antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other melloxacan antibodies in melloxacan level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Lactoferrin(LF)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-220 | Human | Lactoferrin(LF) | Immune support, iron absorption | GMP-SMT-220-Ag01: BSA-Lactoferrin(LF) GMP-SMT-220-Ag02: OVA-Lactoferrin(LF) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Lactoferrin(LF), Lactoferrin(LF) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LF level test of Inflammation/autoimmune/inflammatory disease (Immune support, iron absorption) and related syndrome evaluation. | GMP-SMT-220-Ab01: Anti-Lactoferrin(LF) mouse monoclonal antibody(mAb) GMP-SMT-220-Ab02: Anti-Lactoferrin(LF) human monoclonal antibody(mAb) | Lactoferrin(LF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Lactoferrin(LF) antibodies in LF level test of Inflammation/autoimmune/inflammatory disease (Immune support, iron absorption) and related syndrome evaluation. |
FITC
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-221 | Human | FITC | GMP-SMT-221-Ag01: BSA-FITC GMP-SMT-221-Ag02: OVA-FITC | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-FITC, FITC antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in FITC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-221-Ab01: Anti-FITC mouse monoclonal antibody(mAb) GMP-SMT-221-Ab02: Anti-FITC human monoclonal antibody(mAb) | FITC antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other FITC antibodies in FITC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Histamine
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-222 | Human | Histamine | allergic | GMP-SMT-222-Ag01: BSA-Histamine GMP-SMT-222-Ag02: OVA-Histamine | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Histamine, Histamine antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in Histamine level test of Inflammation/autoimmune/inflammatory disease (allergic) and related syndrome evaluation. | GMP-SMT-222-Ab01: Anti-Histamine mouse monoclonal antibody(mAb) GMP-SMT-222-Ab02: Anti-Histamine human monoclonal antibody(mAb) | Histamine antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Histamine antibodies in Histamine level test of Inflammation/autoimmune/inflammatory disease (allergic) and related syndrome evaluation. |
Cocaine (COC)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-227 | Human | Cocaine (COC) | GMP-SMT-227-Ag01: BSA-Cocaine (COC) GMP-SMT-227-Ag02: OVA-Cocaine (COC) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Cocaine (COC), Cocaine (COC) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-227-Ab01: Anti-Cocaine (COC) mouse monoclonal antibody(mAb) GMP-SMT-227-Ab02: Anti-Cocaine (COC) human monoclonal antibody(mAb) | Cocaine (COC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cocaine (COC) antibodies in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
Cotinine (COT)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
GMP-SMT-228 | Human | Cotinine (COT) | GMP-SMT-228-Ag01: BSA-Cotinine (COT) GMP-SMT-228-Ag02: OVA-Cotinine (COT) | Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Cotinine (COT), Cotinine (COT) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in COT level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. | GMP-SMT-228-Ab01: Anti-Cotinine (COT) mouse monoclonal antibody(mAb) GMP-SMT-228-Ab02: Anti-Cotinine (COT) human monoclonal antibody(mAb) | Cotinine (COT) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cotinine (COT) antibodies in COT level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation. |
GeneMedi’s IL-6 (Interleukin 6) Antibody Pair Validation In Sandwich ELISA Data Post Download
Figure. GeneMedi's IL-6 antibody pair validation with IL-6 antigen (IL-6-Ag01) in sandwich ELISA.
Abbreviation | Description |
IL-6-Ab01 | GMP-h-IL-6-Ab01 |
IL-6-Ab02 | GMP-h-IL-6-Ab02 |
IL6-Ab03 | GMP-h-IL6-Ab03 |
IL-6-Ag01 | GMP-h-IL-6-Ag01 |
GeneMedi’s PCT (procalcitonin) Antibody Pair Validation In Sandwich ELISA Data Post Download
Figure. GeneMedi's PCT antibody pair validation with PCT antigen (PCT-Ag01) in sandwich ELISA.
Abbreviation | Description |
PCT-Ab01 | GMP-h-PCT-Ab01 |
PCT-Ab02 | GMP-h-PCT-Ab02 |
PCT-Ag01 | GMP-h-PCT-Ag01 |